•   
  •   
  •   

US Rapid, cheap home tests: Companies attempt to make coronavirus tests widely available

13:30  24 september  2020
13:30  24 september  2020 Source:   usatoday.com

Testing deal promoted by White House failing to fix lack of Covid-19 screening strategy

  Testing deal promoted by White House failing to fix lack of Covid-19 screening strategy A deal for 150 million rapid coronavirus tests the White House promoted last month as a potential game-changer in battling the pandemic fails to fix the lack of an overarching strategy for a new phase of testing the nation needs to embrace, multiple health experts and state and local officials say. © Alex Wong/Getty Images WASHINGTON, DC - SEPTEMBER 16: U.S. President Donald J. Trump speaks to the press during a news conference in the James Brady Press Briefing Room of the White House on September 16, 2020 in Washington, DC. Trump continues to trail challenger Joe Biden in the polls with the election less than two months away.

But such tests that deliver a rapid result to consumers at home could take weeks, if not months, to hit the market. The U.S. plans to make millions of Antigen tests , if they work, could be cheaply manufactured and administered at home . It's unclear how much these tests would cost, but David R

Coronavirus testing is a delicate task. The companies , whose tests have been mostly greenlit — but not approved in the conventional sense Coronavirus testing is a delicate task. It’s crucial not only to test people at the right time, but also to get the sample from the right place in the nose or throat.

Nearly two months after federal regulators unveiled rules for at-home coronavirus tests, no company has federal approval to sell these fast and cheap tests even though the technology is ready.

a close up of a logo: COVID- testing promo © Ramon Padilla, USA TODAY COVID- testing promo

Molecular PCR tests processed at medical labs remain the standard of accurate testing, but they are more expensive and results can take days to process.

Antigen tests are less expensive, plentiful and deliver results in minutes. Three companies gained Food and Drug Administration authorization to sell antigen testing instruments to labs or clinics. A fourth company, Abbott Laboratories, won approval to market a $5 rapid, credit card-sized test administered by a health care professional.

Meat plant protest, Twisted Sister, water ski show: News from around our 50 states

  Meat plant protest, Twisted Sister, water ski show: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

Several companies are developing rapid , at- home tests , but none have yet won approval. Abbott's new test still requires a nasal swab by a health worker, like most older coronavirus tests . The two additions should help expand the number of available tests .

Another type of test identifies coronavirus proteins in minutes, using a cheap device that’s easy to “To combat this virus, we need to test widely and frequently, and get the results back quickly,” said Most diagnostic tests on the market now hunt for bits of genetic material specific to the coronavirus .

Start the day smarter. Get all the news you need in your inbox each morning.

But no company has been cleared to sell tests directly to consumers for widespread screening – a step some believe is necessary to slow the spread of COVID-19, as more than 200,000 Americans have died and people worry about safely returning to work, school, travel or sporting events.

“The way to get this under control is if people find out as early as possible they are infected and then quarantine from others,” said Dr. Yukari Manabe, a Johns Hopkins University professor of medicine.

The United States needs 30 million tests a week to adequately track the virus and protect vulnerable residents, according to the Rockefeller Foundation. Labs have worked round the clock to gradually bring more tests to Americans over the past six months. Still, the nation reached 1 million daily tests for the first time last week , about one quarter of Rockefeller's goal of more than 4 million tests each day, according to the COVID Tracking Project.

How Trump let Covid-19 win

  How Trump let Covid-19 win Trump’s magical thinking couldn’t beat the coronavirus. America is stuck with the consequences.The US wasn’t able to fully and safely reopen in April. It isn’t able to fully and safely reopen in September.

Test to be validated this week, then made available to healthcare workers and general public.

Faster and cheaper tests are coming, says Evan Jones, CEO of OpGen, a rapid diagnostics Some of the new tests are coming online now, but others will likely take months to validate and ready In the United States, the slow rollout of coronavirus PCR tests has been widely attributed to a combination

Testing in many states and clinics is limited to people exposed to the virus or sick. Routine screening could prevent the spread among people who have the virus but don’t have any symptoms. If people test themselves before going to work, restaurants or school, it could significantly reduce transmission.

The effort to screen people without symptoms is monumental, said Stephen Tang, president and chief executive officer of OraSure Technologies.

“We’ve never had this kind of undertaking in our history,” Tang said.

Rapid test studies underway

With labs stretched to their limits, the extra capacity must come from companies that make portable antigen tests. Large and small companies alike are working toward that goal.

Post-it Note maker 3M has teamed with MIT researchers to develop a rapid, paper-based test. Researchers said the goal is to develop a point-of-care test to deliver quick results outside a lab. Representatives of 3M and MIT declined to say whether they plan to make a test for consumers to use at home.

Fenway voting, teachers staying home, private school boom: News from around our 50 states

  Fenway voting, teachers staying home, private school boom: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

COVID-19 testing involves analyzing samples to assess the current or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or of antibodies produced in response

A rapid test would find these patients quickly, even if it were less sensitive, because their viral loads would quickly rise. PCR tests still have a role, he Highly sensitive PCR tests seemed like the best option for tracking the coronavirus at the start of the pandemic. But for the outbreaks raging now, he

Illinois-based Abbott in August became the first company to gain approval of a rapid antigen test using "lateral flow" technology, similar to a pregnancy test. The U.S. Department of Health and Human Services will spend $750 million to purchase 150 million tests with the first shipments expected this month.

The test must be administered by a healthcare professional such as a physician's assistant or a school nurse. An Abbott spokeswoman declined to say whether the company will seek FDA authorization to sell a home version.

Several other companies are working to bring home tests Americans can purchase without a prescription or doctor's referral.

OraSure sells a rapid HIV test at retailers such as CVS, Walgreens and Walmart. The company has developed a rapid antigen test now in clinical studies. It expects to sell directly to consumers before the end of 2020.

Gaining FDA authorization for these inexpensive, at-home tests is no easy task.

Under the agency’s template, released July 29, the FDA said at-home tests should correctly identify positive cases at least 90% of the time. This sensitivity threshold is higher than antigen tests the agency has authorized for point-of-care or lab settings.

Trump-Biden race to dictate fate of U.S. immigration for generations

  Trump-Biden race to dictate fate of U.S. immigration for generations Biden has pledged to dismantle the president's restrictive immigration policies. But former DHS officials say that could be a long and arduous effort.President Trump's reelection would allow his administration to continue cracking down on unauthorized immigrants, limiting legal immigration and curtailing humanitarian protections for foreigners. During a second term, Mr. Trump could also see through major policy changes to the U.S. immigration system that have so far been stalled by federal courts.

New tests for coronavirus are coming out. Making coronavirus diagnoses faster. Some companies are rolling out point-of-care tests , which are tests that Similar technology is already used for rapid testing for other viruses, such as influenza, said Laura Dullanty, the marketing manager for

Here is how home testing would work. It starts with a telemedicine call with a clinician to determine whether testing is needed. A test kit would then Or get a live video consult if you need support doing the self-swab? We also know that coronavirus tests can have false negatives, particularly if the test

The agency also wants companies to conduct studies on how tests work on patients. The FDA recommends studies with at least 150 people, of which at least 30 people test positive for the virus.

Two companies, Gauss and Cellex, last week announced a rapid antigen test being studied in clinical trials. Gauss developed an app with detailed instructions for users. Cellex's rapid antigen test has demonstrated nearly 90% sensitivity, the FDA's minimum for such tests.

Cambridge, Massachusetts-based E25Bio is studying its antigen test on people without symptoms at a co-working space in the Boston area. The company already has applied to market its rapid antigen test as a diagnostic that can be used at labs. The company wants to gather enough data to apply for at-home testing, said Carlos-Henri Ferré, E25Bio’s director of operations and communications.

Ferré said the FDA's template for at-home testing requires a sensitivity level higher than other forms of antigen testing.

"If we’re talking about a screening device, the parameters don’t need to be the same as an ultimate diagnostic test," he said. "We hope the (FDA's) language would change and reflect what we’re creating, which is a screening tool for public health."

'Feels like a big hole'

Experts say PCR tests that detect the virus's genetic material are the most accurate to detect low levels of the virus. But these tests are processed by labs that need trained workers and sufficient chemical supplies.  If there's a shortage of supplies or workers, test results are delayed. Some major commercial labs took a week or longer to process tests in July, delivering results of little use for consumers.

Trump Warns of More Cases; States Get Rapid Tests: Virus Update

  Trump Warns of More Cases; States Get Rapid Tests: Virus Update President Donald Trump told Americans to expect more coronavirus cases in the weeks ahead as the U.S. deploys millions of rapid tests to states. Warning signs are emerging that the country faces more deaths and serious illnesses as winter approaches. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.getMedianetNativeAds(true); }); The governors of New York and California cautioned of potential upticks in cases. Canada’s two largest provinces are facing new limits on activity after infections spiked.

The antigen tests, which detect proteins, are often less sensitive than PCR tests. But some argue antigen tests, which can produce results in minutes and are less expensive, can identify when a person is infectious and most likely to pass the virus to others.

"From a public health standpoint, the lower sensitivity might not matter if your point is to take people who are infected out of circulation," Manabe said. "Because you are probably going to find all the people with a relatively high viral load using the antigen test."

More: 'Pushing the frontiers': Long lines for COVID tests, stressed labs delay results as demand spikes

More: 'Totally unacceptable': Testing delays force labs to prioritize COVID-19 tests for some, not others

More: FDA tightens oversight of blood tests used to detect coronavirus antibodies

But the FDA also must evaluate other factors, such as how results from antigen tests are publicly reported to public health officials. State and local health departments might not know when someone tests positive or when to dispatch workers to trace the contact of infected individuals.

More than 20 states could not track or do not disclose data on rapid antigen tests, leaving public health officials unable to know the true spread of the virus, Kaiser Health News reported.

Manabe said the FDA's existing stance on at-home testing is an "evolving situation" that might require test developers to use an app or cloud-based device to track test results. Still, requiring consumers to log into an app and voluntarily report their test results might be ineffective.

Tribal voting, third wave, Washington Monument: News from around our 50 states

  Tribal voting, third wave, Washington Monument: News from around our 50 states How the COVID-19 pandemic is affecting every stateStart the day smarter. Get all the news you need in your inbox each morning.

Testing industry officials want to know how the FDA will require test manufacturers to track results

a desk with a computer on a table: A laboratory staff wearing Personal Protective Equipments (PPE) checks details on samples collected for Covid-19 coronavirus testing as part of Project Ummeed, a public-private initiative dealing with large scale Covid-19 RT-PCR tests available for low-income households, at the Metropolis Healthcare Ltd. diagnostic centre in Mumbai on September 16, 2020. - Coronavirus infections in India soared past five million on September 16, as a WHO envoy warned the pandemic was © INDRANIL MUKHERJEE, AFP via Getty Images A laboratory staff wearing Personal Protective Equipments (PPE) checks details on samples collected for Covid-19 coronavirus testing as part of Project Ummeed, a public-private initiative dealing with large scale Covid-19 RT-PCR tests available for low-income households, at the Metropolis Healthcare Ltd. diagnostic centre in Mumbai on September 16, 2020. - Coronavirus infections in India soared past five million on September 16, as a WHO envoy warned the pandemic was "still at the beginning". (Photo by INDRANIL MUKHERJEE / AFP) (Photo by INDRANIL MUKHERJEE/AFP via Getty Images) ORG XMIT: 0 ORIG FILE ID: AFP_8Q44MB.jpg

"The big question that is present in the industry is how will at-home approval be viewed by the FDA?" said Anthony Lemmo, CEO of BioDot, a company that testing supplier. "To just go to CVS and buy it without this information being collected, from an epidemiological point of view, feels like a big hole."

Abbott is pairing its rapid test with a mobile app consumers can use should they need test results to enter places where people gather. The Gauss-Cellex test would require users to take their own nasal swab and scan the rapid test on a mobile app, which would inform the user of the test results.

Peter Pitts, a former FDA associate commissioner and co-founder of the Center for Medicine in the Public Interest, said the FDA must consider the benefits of speed, accuracy and reliability when evaluating any test or product.

"The only thing worse than no data or no testing is bad data based on bad testing," Pitts said. "It sends us into the wrong direction. It compromises people's faith in the system and it doesn’t provide anything useful."

Ken Alltucker is on Twitter as @kalltucker or can be emailed at alltuck@usatoday.com

This article originally appeared on USA TODAY: Rapid, cheap home tests: Companies attempt to make coronavirus tests widely available

How 10 actors who have played Princess Diana compare to the royal .
While Emma Corrin will play Princess Diana in "The Crown," stars like Naomi Watts have already played the royal in TV shows and movies.

—   Share news in the SOC. Networks
usr: 3
This is interesting!